Clinical Trial: Budesonide Treatment for Lymphocytic Colitis
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Efficacy and Safety of Budesonide for Treatment of Lymphocytic Colitis
Brief Summary: The purpose of this study is to determine whether orale budesonide is effective in the treatment of lymphocytic colitis
Detailed Summary: The purpose of this study is to determine whether orale budesonide is effective in the treatment of lymphocytic colitis
Sponsor: Technische Universität Dresden
Current Primary Outcome: Proportion of patients in clinical remission after 6 weeks
Original Primary Outcome: Same as current
Current Secondary Outcome:
- safety
- quality of life
- histological improvement
Original Secondary Outcome: Same as current
Information By: Technische Universität Dresden
Dates:
Date Received: September 9, 2005
Date Started: January 2002
Date Completion:
Last Updated: March 29, 2010
Last Verified: March 2010